Literature DB >> 20713536

The risk of arrhythmias following coronary artery bypass surgery: do smokers have a paradox effect?

Nael Al-Sarraf1, Lukman Thalib, Anne Hughes, Maighread Houlihan, Michael Tolan, Vincent Young, Eillish McGovern.   

Abstract

Smoking is reported to increase the risk of arrhythmias. However, there are limited data on its effects on arrhythmias following coronary artery bypass graft (CABG). This is a retrospective review of a prospective database of all CABG patients over an eight-year period. Our cohort (n=2813) was subdivided into: current (n=1169), former (n=837), and non-smokers (n=807). Predictors of arrhythmias following CABG in relation to smoking status were analysed. Atrial arrhythmias occurred in 942 patients (33%). Ventricular arrhythmias occurred in 48 patients (2%) and high-grade atrioventricular block occurred in five patients (0.2%). Arrhythmias were lower in current smokers than former and non-smokers (29% vs. 40% vs. 39%, respectively P<0.001). Logistic regression analysis showed 30% arrhythmia risk reduction in smokers compared to non-smokers [odds ratio (OR) 0.7, 95% confidence intervals (CI) 0.5-0.8] and this effect persisted after accounting for potential confounders while former smokers had the same risk as non-smokers (OR 1.04, CI 0.9-1.3). There were no significant differences in mortality. Smokers are less prone to develop arrhythmias following CABG. This paradox effect is lost in former smokers. This effect is possibly due to a lower state of hyper adrenergic stimulation observed in smokers than non-smokers following the stress of surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20713536     DOI: 10.1510/icvts.2010.242586

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  1 in total

1.  Association of smoking with postoperative atrial fibrillation in patients with cardiac surgery: A PRISMA-compliant article.

Authors:  Qin Wan; Siyuan Li; Jian Hu
Journal:  Medicine (Baltimore)       Date:  2021-06-11       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.